BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35242182)

  • 1. The Influence of Radiological "Disappearing Lesions" on the Efficacy and Prognosis of Patients with Colorectal Liver Metastases Undergoing Conversion Therapy.
    Song ZY; Yang D; Liu Y; Cheng Y
    Gastroenterol Res Pract; 2022; 2022():2200598. PubMed ID: 35242182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappearing liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Paredes AZ; Moris D; Gavriatopoulou M; Cloyd JM; Pawlik TM
    Surg Oncol; 2019 Jun; 29():7-13. PubMed ID: 31196496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study.
    Han L; Xue J; Wu X; Liang G; Wu Y; Guo F; Gao S; Sun G
    Ann Palliat Med; 2022 Feb; 11(2):717-729. PubMed ID: 35249349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors affecting the success of conversion chemotherapy in patients with unresectable liver metastases from initially colorectal cancer].
    Zhang WL; Zhou C; Deng YX; Hou ZL; Zhang LJ; Lin JZ; Pan ZZ; Lu ZH; Peng JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):56-62. PubMed ID: 35067035
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 6. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
    Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion therapy combined with individualized surgical treatment strategy improves survival in patients with colorectal cancer liver metastases.
    Ma R; Li T
    Int J Clin Exp Pathol; 2021; 14(3):314-321. PubMed ID: 33786148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster?
    Anselmo A; Cascone C; Siragusa L; Sensi B; Materazzo M; Riccetti C; Bacchiocchi G; Ielpo B; Rosso E; Tisone G
    Healthcare (Basel); 2022 Sep; 10(10):. PubMed ID: 36292345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical research progress on disappearing colorectal liver metastases].
    Pan SR; Chen ZY; Zhao K; Liu YC; Wang PY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):1028-1034. PubMed ID: 34823305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel score system for predicting conversion to no evidence of Disease (C-NED) in initially unresectable colorectal cancer liver metastases.
    Li W; Zhou J; Zhang T; Tai Y; Xu Y; Bai Y; Jiang Y; Lu Z; Li L; Huang J; Pan Z; Wu X; Peng J; Lin J
    Am J Cancer Res; 2022; 12(4):1648-1659. PubMed ID: 35530285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy.
    Xu H; Schmidt R; Hamm CA; Schobert IT; He Y; Böning G; Jonczyk M; Hamm B; Gebauer B; Savic LJ
    Ther Adv Med Oncol; 2021; 13():17588359211042304. PubMed ID: 34539817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perioperative chemotherapy in patients with colorectal cancer liver metastasis].
    Xu D; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):321-328. PubMed ID: 31054545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion therapy in patients with colorectal liver metastases.
    Villard C; Habib M; Nordenvall C; Nilsson PJ; Jorns C; Sparrelid E
    Eur J Surg Oncol; 2021 Aug; 47(8):2038-2045. PubMed ID: 33640172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
    He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy.
    Muaddi H; Silva S; Choi WJ; Coburn N; Hallet J; Law C; Cheung H; Karanicolas PJ
    Ann Surg Oncol; 2021 Oct; 28(11):6805-6813. PubMed ID: 33772391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
    Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
    BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
    Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
    BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.